Many patients may keep off lost pounds after stopping a GLP-1, US data suggests
Real-world data suggests weight loss durability post-GLP-1 drug discontinuationStudy suggests weight regain may be less common than clinical…
BGI Genomics, Roche roll out diagnostic tests for Alzheimer’s in China
SHANGHAI, Jan 14 (Reuters) – BGI Genomics (300676.SZ), opens new tab and Roche Diagnostics (ROG.S), opens new tab…
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalledTzield pushed back after adverse event…
US FDA requests removal of suicide warnings from weight-loss drug labels
Jan 13 (Reuters) – The U.S. health regulator asked drugmakers on Tuesday to remove label warnings about a…
Schrodinger to offer Eli Lilly’s AI drug discovery platform on its software
Jan 9 (Reuters) – Schrodinger (SDGR.O), opens new tab said on Friday it is collaborating with Eli Lilly…
US FDA approves Vanda Pharmaceuticals’ motion sickness drug
Dec 30 (Reuters) – Vanda Pharmaceuticals (VNDA.O), opens new tab said on Tuesday its drug for the prevention…
Has the elephant begun stomping in the ground of the bald eagle? — Phar Kim Beng
AUGUST 15 — When reports emerged that India had “sent a circular to BRICS granting full rupee access”…